Table 1.
Baseline Characteristics Of The Included 1055 Patients With HBV-Related HCC
| Variables | Patient Population (n = 1055) |
|---|---|
| Age (≥60/<60 yrs) | 162 (15.4%)/893 (84.6%) |
| Sex (male/female) | 921 (87.3%)/134 (12.7%) |
| Total bilirubin (μmol/L) | 12.4 (2.7 ~66.8) |
| Albumin (g/L) | 40.9 (24.9 ~54.4) |
| Aspartate aminotransferase (U/L) | 42 (14 ~459) |
| Platelet count (109/L) | 172 (12 ~668) |
| Prothrombin time (sec) | 12.9 (9.4 ~22.4) |
| AFP (≥400/<400 ng/mL) | 432 (40.9%)/623 (59.1%) |
| CSPH | 219 (20.8%) |
| Ascites | 183 (17.3%) |
| C-P grade (A/B/C) | 1008 (95.5%)/47 (4.5%)/0 (0%) |
| C-P score | 5 (5–9) |
| ALBI score | −2.77 (−3.91 ~ −1.14) |
| APRI score | 0.64 (0.11 ~23.75) |
| Tumor size (cm) | 6.0 (1.0 ~25.0) |
| Tumor number (≥3/<3) | 128 (12.1%)/927 (87.9%) |
| Extent of resection (major/minor) | 220 (20.9%)/835 (79.1%) |
| Blood loss (>400/≤400 mL) (n) | 338 (32.0%)/717 (68.0%) |
Abbreviations: AFP, alpha fetoprotein; CSPH, clinically significant portal hypertension; C-P, Child-Pugh; ALBI, albumin–bilirubin; APRI, aspartate aminotransferase to platelet ratio index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.